J-Star to sponsor a MBO of Apo Plus

J-Star has sponsored an MBO of Apo Plus Station, a provider of contract marketing services to drug and medical devise industries. J-Star made an equity investment of JPY 0.43 billion (USD 5 million) to hold a majority stake. Apo Plus is the second largest CSO in Japan and its annual sales were JPY 5.5 billion (USD 65 million) for the March 2010 period. It plans to increase its medical representatives from the current staff of 350 to 550 in the next 3 years.